Effect of Normobaric Hypoxia on Exercise Performance in Pulmonary Hypertension: Randomized Trial.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
02 2021
Historique:
received: 15 05 2020
revised: 24 08 2020
accepted: 04 09 2020
pubmed: 13 9 2020
medline: 14 9 2021
entrez: 12 9 2020
Statut: ppublish

Résumé

Many patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension (PH) wish to travel to altitude or by airplane, but their risk of hypoxia-related adverse health effects is insufficiently explored. How does hypoxia, compared with normoxia, affect constant work-rate exercise test (CWRET) time in patients with PH, and which physiologic mechanisms are involved? Stable patients with PH with resting Pao Twenty-eight patients (13 women) were included: median (quartiles) age, 66 (54; 74) years; mean pulmonary artery pressure, 41 (29; 49) mm Hg; and pulmonary vascular resistance, 5.4 (4; 8) Wood units. Under normoxia and hypoxia, CWRET times were 16.9 (8.0; 30.0) and 6.7 (5.5; 27.3) min, respectively, with a median difference (95% CI) of -0.7 (-3.1 to 0.0) min corresponding to -7 (-32 to 0.0)% (P = .006). At end-exercise in normoxia and hypoxia, respectively, median values and differences in corresponding variables were as follows: Pao In patients with PH, short-time exposure to hypoxia was well tolerated but reduced CWRET time compared with normoxia in association with hypoxemia, lactacidemia, and hypocapnia. Because pulmonary hemodynamics and dyspnea at end-exercise remained unaltered, the hypoxia-induced exercise limitation may be due to a reduced oxygen delivery causing peripheral tissue hypoxia, augmented lactic acid loading and hyperventilation. ClinicalTrials.gov; No.: NCT03592927; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
Many patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension (PH) wish to travel to altitude or by airplane, but their risk of hypoxia-related adverse health effects is insufficiently explored.
RESEARCH QUESTION
How does hypoxia, compared with normoxia, affect constant work-rate exercise test (CWRET) time in patients with PH, and which physiologic mechanisms are involved?
STUDY DESIGN AND METHODS
Stable patients with PH with resting Pao
RESULTS
Twenty-eight patients (13 women) were included: median (quartiles) age, 66 (54; 74) years; mean pulmonary artery pressure, 41 (29; 49) mm Hg; and pulmonary vascular resistance, 5.4 (4; 8) Wood units. Under normoxia and hypoxia, CWRET times were 16.9 (8.0; 30.0) and 6.7 (5.5; 27.3) min, respectively, with a median difference (95% CI) of -0.7 (-3.1 to 0.0) min corresponding to -7 (-32 to 0.0)% (P = .006). At end-exercise in normoxia and hypoxia, respectively, median values and differences in corresponding variables were as follows: Pao
INTERPRETATION
In patients with PH, short-time exposure to hypoxia was well tolerated but reduced CWRET time compared with normoxia in association with hypoxemia, lactacidemia, and hypocapnia. Because pulmonary hemodynamics and dyspnea at end-exercise remained unaltered, the hypoxia-induced exercise limitation may be due to a reduced oxygen delivery causing peripheral tissue hypoxia, augmented lactic acid loading and hyperventilation.
TRIAL REGISTRY
ClinicalTrials.gov; No.: NCT03592927; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 32918899
pii: S0012-3692(20)34370-1
doi: 10.1016/j.chest.2020.09.004
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03592927']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-771

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Simon R Schneider (SR)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

Laura C Mayer (LC)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Mona Lichtblau (M)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Charlotte Berlier (C)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Esther I Schwarz (EI)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Stéphanie Saxer (S)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Michael Furian (M)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Konrad E Bloch (KE)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland.

Silvia Ulrich (S)

Clinic of Pulmonology, University Hospital of Zurich, Zurich, Switzerland. Electronic address: silvia.ulrich@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH